This site contains current information on validated measures developed by Pfizer in various therapeutic areas including CV/METABOLIC, NEUROSCIENCE, ONCOLOGY, PAIN, RARE DISEASES, SEXUAL HEALTH, UROLOGY, and WOMEN’S HEALTH. It is designed to be a resource for up-to-date versions and translations of many available measures used to assess patient-reported outcomes.
Please note that some measures are designed to be used for clinical research for outcome assessment and some measures are designed to be used as a screening tool (Please see SCREENERS).
Measures are not designed to be used as a diagnostic tool.
Measures found under each of these main therapeutic areas include detailed background information and relevant references.
Measures may be ordered by going to the ORDER MEASURES page. Please note that fees may apply for use.
TRANSLATIONS are available in a variety of languages.
All measures will be emailed with a scoring manual and translation certificate.
Please be advised that all measures have been developed to be completed via paper unless otherwise indicated. Equivalence testing may be required when a measure is migrated from paper to an electronic device (e.g., ePRO, web-based, IVRS). Please provide screenshots/scripts (where appropriate) of migrated measures so that we may ensure that the intent of the paper version has been replicated.
Coons et al., 2009:12(4);419-429.